← Leaderboards
Sriram Vaidyanathan
Stanford University
$1,080,072
Attributed
$1,080,072
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $415.5K · FY2021–24$500K$375K$250K$125K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$1,080,072 · 2
By mechanism
R00$747,000 · 1
K99$333,072 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Le Cong$4,606,066
- Melissa L Bondy$46,044,245
- Benjamin Deneen$20,916,041
- Matthew Neil Bainbridge$4,619,206
- Richard S Lewis$12,935,154
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectAdultAirway DiseaseAllelesAutologous TransplantationAgarBase PairingBronchial EpitheliumCause Of DeathCd19 GeneCellsCell TherapyCell TypeCellular BiologyCellular TransductionChildClinical ApplicationCodeComplementary DnaCystic FibrosisCystic Fibrosis PatientsCystic Fibrosis Transmembrane Conductance RegulatorDelta F508 MutationDependovirus
Grant awards (5)
A universal genome editing strategy to develop an airway stem cell therapy for cystic fibrosis$249,000
R00 · FY2024 · HL · contact PI
A universal genome editing strategy to develop an airway stem cell therapy for cystic fibrosis$249,000
R00 · FY2023 · HL · contact PI
A universal genome editing strategy to develop an airway stem cell therapy for cystic fibrosis$249,000
R00 · FY2022 · HL · contact PI
A universal genome editing strategy to develop an airway stem cell therapy for cystic fibrosis$166,536
K99 · FY2022 · HL · contact PI
A universal genome editing strategy to develop an airway stem cell therapy for cystic fibrosis$166,536
K99 · FY2021 · HL · contact PI